ArticleAnalytical chemistry2025
Single Molecule Kinetic Fingerprinting of Glycans on IgA1 Antibodies.
Article in Analytical chemistry, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Deciphering the Underlying Mechanisms Linking Psoriasis and IgA Nephropathy.Journal of immunology research · 2026Review
- Glycan Signatures on Neutrophils in an Equine Model for Autoimmune Uveitis.Biomolecules · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
Abstract
Immunoglobulin A (IgA) nephropathy is the most common form of primary glomerulonephritis and is triggered by damage to glomeruli from deposition of complexes formed between glycosylated IgA1 antibodies that are "galactose-deficient" and antibodies directed to these aberrant proteins. Currently, galactose deficiencies are detected with ensemble measurements, e.g., via mass spectrometry or liquid chromatography, which only measure average glycan-IgA1 ratios, but cannot resolve heterogeneity of O-glycosylation between different IgA1 populations. To resolve these differences at the single molecule level, we developed an assay to detect the glycosylation state of individual IgA1 using single molecule fluorescence microscopy. By using fluorescence resonance energy transfer (FRET), high concentrations of fluorescently labeled probes with low binding rates can be employed to observe the binding of protein probes to surface adhered target molecules and obtain their kinetic fingerprints. We measured the binding and unbinding rates of jacalin (a lectin binding to O-linked glycans) to individual IgA1 molecules on a glass surface. Adding galactose decreased binding, which demonstrated that the jacalin probe binds specifically to O-linked glycans on the hinge region of IgA1. This result is a first step toward using kinetic fingerprinting to sequence glycans on IgA1.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.